For over 50 years, Bloomberg Tax’s renowned flagship daily news service, Daily Tax Report® has helped leading practitioners and policymakers stay on the cutting edge of taxation and...
Aug. 30 — New Jersey retailers who sell EpiPens at a discount would qualify for a tax break under a bill soon to be proposed in the New Jersey Legislature.
Under the proposal, retailers that sell the drug at the 2009 price of $100 for a two-pack would qualify for a tax credit for the difference in price, according to Sen. Kevin O'Toole (R), who plans to introduce the legislation.
The price of the auto-injectors, used to stop life-threatening allergic reactions such as those triggered by food allergies, has ballooned to more than $600 for a two-pack, up from about $57 for a single pen in 2007. Under fire from lawmakers, Mylan NV, the maker of EpiPens, said Aug. 29 that it will start selling a generic version of the drug at about half the price.
“I am appalled by reports of Mylan's monopolostic pricing tactics that are forcing retailers and families to pay an astronomical amount of money for one of the only drugs that can save a child's life during an anaphylactic attack,” O'Toole said in an Aug. 26 statement.
The bill hasn't been formally introduced because the Senate hasn't had a quorum, a spokeswoman for O'Toole told Bloomberg BNA Aug. 30.
O'Toole also sponsored legislation in 2015 that required all schools to maintain supplies of epinephrine.
To contact the reporter on this story: Leslie A. Pappas in Philadelphia at firstname.lastname@example.org
To contact the editor responsible for this story: Ryan Tuck at email@example.com
O'Toole's announcement is at http://src.bna.com/iav.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
Notify me when updates are available (No standing order will be created).
Put me on standing order
Notify me when new releases are available (no standing order will be created)